References
1. The structure of rubromycin: H. Brockmann, et al.; THL 30: 3525 (1966). 2. Rubromycin II: H. Brockmann, et al.; Chem. Ber. 102: 126 (1969). 3. Rubromycins. 3. The constitution of alpha-rubromycin, beta-rubromycin, gamma-rubromycin, and gamma- iso-rubromycin: H. Brockmann & A. Zeeck; Chem. Ber. 103: 1709 (1970). 4. Inhibition of human immunodeficiency virus-1 reverse transcriptase activity by rubromycins: competitive interaction at the template.primer site: M.E. Goldman, et al.; Mol. Pharmacol. 38: 20 (1990). 5. Inhibition of human telomerase by rubromycins: implication of spiroketal system of the compounds as an active moiety: T. Ueno, et al.; Biochemistry 39: 5995 (2000). 6. Structural and biosynthetic investigations of the rubromycins: C. Puder, et al.; Eur. J. Org. Chem. 2000: 729 (2000). 7. Rubromycins: Structurally intriguing, biologically valuable, synthetically challenging antitumour antibiotics: M. Brasholz, et al.; Eur. J. Org. Chem. 2007: 3801 (2007)USBio References
No references available